Expression, purification and characterisation of a human anti-CDK4 single-chain variable fragment antibody

BACKGROUND: Cyclin-dependent kinase 4 (CDK4) when hyperactivated drives development and maintenance of most tumour types, thus prompting its use as an essential cancer treatment target and a diagnostic tool. Target-binding molecules, such as single-chain variable fragment (scFv) antibodies, hold tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jialiang, Xu, Jingjing, Yang, Tianbin, Yu, Xinze, Cheng, Cheng, Zhang, Tong, Ren, Ze, Li, Na, Yang, Fang, Li, Guiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690526/
https://www.ncbi.nlm.nih.gov/pubmed/34930213
http://dx.doi.org/10.1186/s12896-021-00729-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690526/
https://www.ncbi.nlm.nih.gov/pubmed/34930213
http://dx.doi.org/10.1186/s12896-021-00729-z

Ejemplares similares